These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
403 related articles for article (PubMed ID: 17943030)
61. Discontinuation of risperidone in Alzheimer's disease. Gnjidic D; Hilmer SN N Engl J Med; 2013 Jan; 368(2):186. PubMed ID: 23301738 [No Abstract] [Full Text] [Related]
62. Discontinuation of risperidone in Alzheimer's disease. Devanand DP; Schultz SK; Sultzer DL N Engl J Med; 2013 Jan; 368(2):187-8. PubMed ID: 23301737 [No Abstract] [Full Text] [Related]
63. Management of the agitated patient. A pharmacological update. McGough JJ; Bona JR N C Med J; 1988 Oct; 49(10):497-9. PubMed ID: 2903452 [No Abstract] [Full Text] [Related]
64. E-FALCONS. A mnemonic for monitoring the prescribing of atypical antipsychotics. Gill T; Khouzam HR; Tan DT Geriatrics; 2004 Aug; 59(8):41-2, 45. PubMed ID: 15332416 [No Abstract] [Full Text] [Related]
65. Psychosis-related disturbances. Psychosis, agitation, and disinhibition in Alzheimer's disease: definitions and treatment options. Lesser JM; Hughes S Geriatrics; 2006 Dec; 61(12):14-20. PubMed ID: 17184138 [TBL] [Abstract][Full Text] [Related]
66. Clozapine use in treatment-resistant agitation in the setting of dementia. Bastiampillai T; Dhillon R; French TH Aust N Z J Psychiatry; 2009 Jul; 43(7):689-90. PubMed ID: 19530027 [No Abstract] [Full Text] [Related]
67. [Longterm treatment with Risperidone in Alzheimer's disease? No justification for more "drug deaths" in nursing homes!]. Förstl H Dtsch Med Wochenschr; 2013 Jan; 138(1-2):16. PubMed ID: 23250689 [No Abstract] [Full Text] [Related]
68. The antipsychotic discontinuation in Alzheimer disease trial: clinical rationale and study design. Devanand DP; Mintzer J; Schultz S; Sultzer D; de la Pena D; Gupta S; Colon S; Schimming C; Pelton GH; Andrews H; Levin B Am J Geriatr Psychiatry; 2012 Apr; 20(4):362-73. PubMed ID: 21407047 [TBL] [Abstract][Full Text] [Related]
69. [Atypical neuroleptics in dementia. Managing behavioral disorders early and efficiently]. MMW Fortschr Med; 2002 Mar; 144(10):60-1. PubMed ID: 11928271 [No Abstract] [Full Text] [Related]
70. Challenges in the management of psychotic symptoms in long-term care. Gravenstein S; Beier M; Singer C J Am Med Dir Assoc; 2003; 4(4 Suppl):H17-20. PubMed ID: 12857363 [No Abstract] [Full Text] [Related]
71. Antidepressants for agitation and psychosis in patients with dementia. Bui Q Am Fam Physician; 2012 Jan; 85(1):20-2. PubMed ID: 22230303 [No Abstract] [Full Text] [Related]
72. Nursing home research from investigators' perspective. Finkel SI; Lyons J Int Psychogeriatr; 1996; 8 Suppl 3():371-3; discussion 381-2. PubMed ID: 9154591 [No Abstract] [Full Text] [Related]
73. Involving the resident/decision maker in antipsychotic medication use. Mort JR S D Med; 2013 Apr; 66(4):148-9. PubMed ID: 23697039 [No Abstract] [Full Text] [Related]
74. [Risks associated with parenteral treatment of acute agitation]. Boomsma MM; Mengels O; van Olden RW Tijdschr Psychiatr; 2006; 48(2):135-9. PubMed ID: 16958197 [TBL] [Abstract][Full Text] [Related]
75. [Indications for, limitations, and hazards of neuroleptic agents]. Hoes MJ Ned Tijdschr Geneeskd; 1980 Apr; 124(17):647-53. PubMed ID: 6104304 [No Abstract] [Full Text] [Related]
76. The management of agitation in demented patients with propranolol. Summers WK J Alzheimers Dis; 2006 Mar; 9(1):69-75. PubMed ID: 16627936 [TBL] [Abstract][Full Text] [Related]
77. [Atypical antipsychotics and dementia]. Sundal E Tidsskr Nor Laegeforen; 2004 Oct; 124(20):2664. PubMed ID: 15534657 [No Abstract] [Full Text] [Related]